LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Elevated C-Reactive Protein Found in H7N9 Influenza Infection

By LabMedica International staff writers
Posted on 13 Mar 2016
Print article
The IMMAGE 800 Immunochemistry System
The IMMAGE 800 Immunochemistry System (Photo courtesy of BECKMAN COULTER, INC - Danaher)
The avian influenza H7N9 virus can cause cytokine overproduction and result in severe pneumonia and acute respiratory distress syndrome; and many studies have focused on hypercytokinemia during avian influenza infection.

C-reactive protein (CRP) is synthesized primarily by the liver, and is one of the nonspecific acute-phase proteins produced in response to most forms of infection inflammation, and tissue injury. This protein has been considered a nonspecific biomarker for early diagnosis and prognostic measurements.

Infectious disease specialists at the Zhejiang University (Hangzhou, China) recruited 82 patients with laboratory-confirmed H7N9 infections from April 2013 to February 2014, and 14 patients with H1N1 virus in Beijing from December 2012 to February 2013, as well as six healthy volunteers as controls. Plasma samples were collected within two days of admission. Patient sputum samples or pharyngeal swabs were collected on the same day. Viral load was detected by TaqMan real-time reverse transcription polymerase chain reaction (PCR) targeting the influenza A H7N9 virus subtype-specific H7 gene or influenza A H1N1 virus subtype-specific H1 and N1 genes using standard thermal cycling conditions.

A Bio-Plex Pro Human 27-plex cytokine group I assay kit (Bio-Rad; Hercules, CA, USA) was used to measure the concentrations of plasma cytokines. Samples were analyzed using a MAGPIX system (Luminex Corporation, Merck Millipore; Temecula, CA, USA). Cytokine/chemokine values that were detected outside of the standard range were flagged as high or low out-of-range (OOR), and the highest or lowest value on the standard curve was used instead of the OOR measurement. Measurement of CRP in patient plasma was detected using a Beckman-Coulter IMMAGE 800 Immunohistochemistry System and Beckman-Coulter reagents (Beckman-Coulter; Brea, CA, USA).

The CRP levels were much higher in patients with H7N9 infection than in patients with H1N1 infection, 84.0 ± 65.2 mg/L compared to 11.37 ± 6.70 mg/L. The CRP concentration of the H1N1 group was significantly lower than those in the survivor and non-survivor H7N9 groups. Patients with H7N9 who died had much higher concentrations of CRP of 129.6 ± 63.9 mg/L. Several cytokines, including Macrophage inflammatory protein-1β (MIP-1β), Monocyte chemoattractant protein-1(MCP-1), Interferon gamma-induced protein 10 (IP-10), and interleukin-6 (IL-6), were observed to have significantly positive relationships with CRP levels, whereas IL-17A was negatively associated with CRP levels.

The authors concluded that CRP, as a conventional clinical indicator, could be a simple and convenient marker for the early prediction of potential cytokine storms, particularly when cytokine detection is unavailable. This marker will contribute to the early identification of high-risk cases, further assessment of cytokine profiles of severe cases, and the development of an appropriate therapeutic plan, such as anti-cytokine treatment. The study was published in the March 2016 edition of the International Journal of Infectious Disease.

Related Links:

Zhejiang University 
Luminex Corporation
Beckman-Coulter 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more